Inogen (INGN) Posts Q4 Loss of $0.03, Revs Beat; Outlook Raised
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Inogen, Inc (INGN) PT Raised to $150 at Needham & Company; Domestic B2B and DTC Sales Drive Results
February 28, 2018 7:17 AM ESTNeedham & Company raised its price target on Inogen, Inc (NASDAQ: INGN) to $150.00 (from $125.00) while maintaining a Strong Buy rating.
Analyst Mike Matson commented, "INGN beat consensus revenue, EBITDA, and EPS in 4Q17. Management raised its 2018 revenue and net income guidance and maintained its... More
